Adipocyte fatty acid binding protein in a Caucasian population: A new marker of metabolic syndrome?

European Journal of Clinical Investigation

Volumn 36, Issue 9, 2006, Pages 621-625

  Stejskal, D ^a   Karpisek, M ^b  

^a Sternberk Hospital   (Czech Republic)

^b UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

Author keywords

A FABP; Metabolic syndrome; Obesity

Indexed keywords

ADIPOCYTE FATTY ACID BINDING PROTEIN; CHOLESTEROL; FATTY ACID BINDING PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; URIC ACID;

ANTHROPOMETRY; ARTICLE; BODY MASS; CAUCASIAN; CHI SQUARE DISTRIBUTION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIET RESTRICTION; DISEASE MARKER; FEMALE; HUMAN; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; QUICKI QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; ROC CURVE; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; WAIST CIRCUMFERENCE;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; BODY SIZE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; INSULIN; MALE; METABOLIC SYNDROME X; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TRIGLYCERIDES;

EID: 33747031136     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2006.01696.x     Document Type: Article

References (13)

1. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
2. Xu A, Wang Y, Xu JY, Stejskal D, Tam S, Zhang J et al. Adipocyte fatty acid binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem 2006;52:405-13.
3. Makowski L, Hotamisligil GS. Fatty acid binding proteins - the evolutionary crossroads of inflammatory and metabolic responses. J Nutr 2004;134:2464-8.
4. Boord JB, Fazio S, Linton MF. Cytoplasmatic fatty acid-binding proteins. emerging roles in metabolism and atherosclerosis. Curr Opin Lipidol 2002;13:141-7.
5. Baar RA, Dingfelder CS, Smith LA. Bernlohr DA, Wu C, Lange AJ et al. Investigation of in vivo fatty acid metabolism in A-FABP/aP2 (-/-) mice. Am J Physiol Endocrinol Metab 2005;288:E187-93.
6. Fu Y, Luo N, Lopes-Virella MF. Oxidised LDL induces the expression of A-FABP/aP2 mRNA 17 and protein in human THP-1 macrophages. J Lipid Res 2000;41:2017-23.
7. Llaverias G, Noe V, Penuelas S, Vazquez-Carrera M, Sanchez RM, Laguna JC et al. Atorvastatin reduces CD68, FABP4, and HBP expression in oxLDL-treated human macrophages. Biochem Biophys Res Commun 2004;318:265-74.
8. Zimmer JS, Dyckes DF. Bernlohr DA, Murphy RC. Fatty acid binding protein stabilize leukotriene A4. J Lipid Res 2004;45:2138-44.
9. Hertzel AV. Bernlohr DA. The mammalian fatty acid-binding protein multigenes family: molecular and genetic insights into function. Trends Endocrinol Metab 2000;11:175-80.
10. Liu MY, Xydakis AM, Hoogeveen RC, Jones PH, Smith EO, Nelson KW et al. Multiplexed analysis of biomarkers related to obesity and the metabolic syndrome in human plasma, using the Luminex-100 system. Clin Chem 2005;51:1102-9.
11. Katz A, Nambi SS, Kieren Mather K, Baron AD. Follmann DA, Sullivan G et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-10.
12. Hrebicek J, Janout V, Malincikova J, Horakova D, Cizek L. Detection of insulin resistance by simple quantitative insulin sensitivity check index Quicki for epidemiological assessment and prevention. J Clin Endocrinol Metab 2002;87:144-7.
13. Klabunde RE. Cardiovascular Physiology Concepts. In: http://www. cvphysiology.com/Blood%20Pressure/BP006.htm.